CAMBRIDGE, UK, May 8 - The public-private effort to sequence the mouse genome said Tuesday it has completed the first phase of its sequencing initiative.

The Mouse Sequencing Consortium has generated 3x coverage of the mouse genetic code, where each of the three billion DNA bases has been ‘read’ three times. Approximately 94 percent of the genome is now covered. 

The organisations that make up the $58 million consortium include the US National Institutes of Health, the Wellcome Trust, Glaxo SmithKline, the Merck Genome Research Institute and Affymetrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.